matlab © 2018 (Wolters Kluwer Health)
90
Structured Review
Wolters Kluwer Health
matlab © 2018
Matlab © 2018, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/matlab+%C2%A9+2018/matlab+++2018/10__1097_slash_rlu__0000000000001991-86-7-9
Average 90 stars, based on 1 article reviews
Matlab © 2018, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/matlab+%C2%A9+2018/matlab+++2018/10__1097_slash_rlu__0000000000001991-86-7-9
Average 90 stars, based on 1 article reviews
matlab © 2018 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate Cancer Article Snippet: Background: Tc-MIP-1404 (Progenics Pharmaceuticals, Inc, New York, NY) is a novel ligand binding to prostate-specific membrane antigen suitable for SPECT.. There are, as yet, no data concerning its use in whole-body primary staging and its interobserver variability in patients with prostate cancer (PC) prior to therapy.. Methods: A search of our clinical database from April 2013 to May 2017 yielded 93 patients with histologically confirmed cancer in whom TcMIP-1404 SPECT/CT had been performed for primary whole-body staging before therapy.Whole-body planar and SPECT/CT images of the lower abdomen and thorax had been obtained 3 to 4 hours postinjection of 706 ± 72MBq Tc-MIP-1404. |